NDC 72205-205-01 - ziprasidone mesylate

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
72205-205
Requested NDC
72205-205-01
Package NDCs from labels
72205-205-01, 72205-205-07
Manufacturer
Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED
Effective date
2025-08-25
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
ZIPRASIDONE - Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITEDNovadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED2025-08-25Human Prescription Drug Label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72205-205-01ziprasidone mesylate1 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,12
72205-205-07ziprasidone mesylate10 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,102

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72205-205ZIPRASIDONE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NOVADOZ PHARMACEUTICALS LLC]1Current NDC, Legacy NDC, 2 package rows20220920_90b35a26-ab65-4c39-b97f-55c8c0e34b0b.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72205-205-01EA - Each72205-2056f0ed70f-d34d-4ff6-b48c-9c6ec9718f3d12023-06-06
72205-205-07EA - Each72205-205e198e55f-c05f-4964-b9b7-fd70ba00750012023-06-06

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ziprasidone MesylateZIPRASIDONE MESYLATESTERISCIENCE SPECIALTIES PRIVATE LIMITED1ffd16c3-25ac-4839-9ea9-4efd32926b952025-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351223
unii: 3X6SAX83JZ
ziprasidone mesylateZIPRASIDONE MESYLATENovadoz Pharmaceuticals LLC90b35a26-ab65-4c39-b97f-55c8c0e34b0b2025-08-25Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA216091
ndc (package): 72205-205-01
ndc (package): 72205-205-07
ndc (product): 72205-205
ndc11 (package): 72205020501
rxcui: 351223
spl id: 4e003e80-c860-4b03-81e2-6662324096d4
spl set id: 90b35a26-ab65-4c39-b97f-55c8c0e34b0b
unii: 3X6SAX83JZ
Ziprasidone MesylateZIPRASIDONE MESYLATEFosun Pharma USA Inc.b28a4f3d-0aae-050d-e053-2995a90aa4a62025-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351223
unii: 3X6SAX83JZ
Ziprasidone MesylateZIPRASIDONE MESYLATEFosun Pharma USA Inc.90f55022-8d58-4bfb-9464-9bf11395ae172025-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351223
unii: 3X6SAX83JZ
ziprasidone mesylateZIPRASIDONE MESYLATEGland Pharma Limited77a10f48-e300-465f-81b5-54be38daa4b32025-03-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351223
unii: 3X6SAX83JZ
ZIPRASIDONE MESYLATEZIPRASIDONE MESYLATEHF Acquisition Co LLC, DBA HealthFirstc75971f8-9640-a6e8-e053-2995a90af6542024-01-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351223
unii: 3X6SAX83JZ
ziprasidone mesylateZIPRASIDONE MESYLATEDr.Reddy's Laboratories, Inc.3cb79985-1207-602e-2dda-a118133b4c602021-07-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351223
unii: 3X6SAX83JZ
ziprasidone mesylateZIPRASIDONE MESYLATEDr.Reddy's Laboratories, Inc.6fd6fc45-20c4-e223-3532-ce37aa02b71c2021-07-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351223
unii: 3X6SAX83JZ

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.